ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,082,000 | +134.7% | 12,096 | +84.9% | 0.01% | +125.0% |
| Q1 2021 | $887,000 | +25.6% | 6,542 | +18.5% | 0.00% | 0.0% |
| Q4 2020 | $706,000 | +134.6% | 5,519 | +74.5% | 0.00% | +100.0% |
| Q2 2020 | $301,000 | +106.2% | 3,162 | +94.8% | 0.00% | +100.0% |
| Q1 2020 | $146,000 | -99.2% | 1,623 | -99.6% | 0.00% | -98.9% |
| Q1 2019 | $19,404,000 | +43020.0% | 416,666 | +40392.3% | 0.09% | – |
| Q4 2018 | $45,000 | -92.1% | 1,029 | -93.4% | 0.00% | -100.0% |
| Q3 2016 | $568,000 | – | 15,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |